STJ NYSE
St. Jude Medical, Inc.
1W: +0.8%
1M: +2.3%
3M: +1.2%
1Y: +33.0%
3Y: +32.1%
5Y: +135.6%
$80.82
Last traded 2017-01-04 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$13.1B
+28.0% ▲
Total Liabilities
$9.0B
+50.2% ▲
Shareholders Equity
$4.0B
-3.7% ▼
5Y CAGR: -1.6%
Cash & Investments
$677M
-54.0% ▼
5Y CAGR: +6.2%
Total Debt
$6.4B
+65.3% ▲
5Y CAGR: +20.5%
Net Debt
$5.7B
+136.2% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $986M | $1.2B | $1.4B | $1.4B | $667M |
| Short-Term Investments | $232M | $220M | $35M | $30M | $10M |
| Cash & ST Investments | $1.2B | $1.4B | $1.4B | $1.5B | $677M |
| Net Receivables | $1.4B | $1.3B | $1.4B | $1.2B | $1.2B |
| Inventory | $624M | $610M | $708M | $784M | $909M |
| Other Current Assets | $181M | $178M | $372M | $443M | $442M |
| Total Current Assets | $3.4B | $3.6B | $3.9B | $3.9B | $3.3B |
| Property, Plant & Equip. | $1.4B | $1.4B | $1.4B | $1.3B | $1.3B |
| Goodwill & Intangibles | $3.8B | $3.8B | $4.4B | $4.4B | $7.9B |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $185M | $310M | $377M | $454M | $470M |
| Total Non-Current Assets | $5.6B | $5.7B | $6.3B | $6.3B | $9.8B |
| Total Assets | $9.0B | $9.3B | $10.2B | $10.2B | $13.1B |
| — Liabilities — | |||||
| Accounts Payable | $202M | $254M | $247M | $151M | $201M |
| Short-Term Debt | $83M | $530M | $62M | $1.6B | $1.2B |
| Deferred Revenue | $232M | $220M | $229M | $291M | $264M |
| Other Current Liabilities | $544M | $771M | $842M | $631M | $845M |
| Total Current Liabilities | $1.1B | $1.8B | $1.4B | $2.7B | $2.5B |
| Long-Term Debt | $2.7B | $2.5B | $3.5B | $2.3B | $5.2B |
| Other Non-Current Liab. | $477M | $529M | $706M | $784M | $582M |
| Total Non-Current Liabilities | $3.5B | $3.4B | $4.5B | $3.3B | $6.5B |
| Total Liabilities | $4.5B | $5.2B | $6.0B | $6.0B | $9.0B |
| — Equity — | |||||
| Common Stock | $32M | $30M | $29M | $29M | $28M |
| Retained Earnings | $4.4B | $4.0B | $3.9B | $4.2B | $4.2B |
| Accumulated OCI | $18M | $20M | $46M | -$173M | -$345M |
| Total Stockholders Equity | $4.5B | $4.1B | $4.2B | $4.2B | $4.0B |
| Total Liabilities & Equity | $9.0B | $9.3B | $10.2B | $10.2B | $13.1B |
| — Key Metrics — | |||||
| Total Debt | $2.8B | $3.1B | $3.6B | $3.9B | $6.4B |
| Net Debt | $1.8B | $1.9B | $2.2B | $2.4B | $5.7B |
| Total Investments | $232M | $220M | $35M | $30M | $10M |